Cargando…

Coagulation abnormalities in critically ill patients

Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. There are many causes for a deranged coagulation in critically ill patients and each of these u...

Descripción completa

Detalles Bibliográficos
Autores principales: Levi, Marcel, Opal, Steven M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750988/
https://www.ncbi.nlm.nih.gov/pubmed/16879728
http://dx.doi.org/10.1186/cc4975
_version_ 1782131400615395328
author Levi, Marcel
Opal, Steven M
author_facet Levi, Marcel
Opal, Steven M
author_sort Levi, Marcel
collection PubMed
description Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. There are many causes for a deranged coagulation in critically ill patients and each of these underlying disorders may require specific therapeutic or supportive management. In recent years, new insights into the pathogenesis and clinical management of many coagulation defects in critically ill patients have been accumulated and this knowledge is helpful in determining the optimal diagnostic and therapeutic strategy.
format Text
id pubmed-1750988
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17509882006-12-27 Coagulation abnormalities in critically ill patients Levi, Marcel Opal, Steven M Crit Care Review Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. There are many causes for a deranged coagulation in critically ill patients and each of these underlying disorders may require specific therapeutic or supportive management. In recent years, new insights into the pathogenesis and clinical management of many coagulation defects in critically ill patients have been accumulated and this knowledge is helpful in determining the optimal diagnostic and therapeutic strategy. BioMed Central 2006 2006-07-19 /pmc/articles/PMC1750988/ /pubmed/16879728 http://dx.doi.org/10.1186/cc4975 Text en Copyright © 2006 BioMed Central Ltd
spellingShingle Review
Levi, Marcel
Opal, Steven M
Coagulation abnormalities in critically ill patients
title Coagulation abnormalities in critically ill patients
title_full Coagulation abnormalities in critically ill patients
title_fullStr Coagulation abnormalities in critically ill patients
title_full_unstemmed Coagulation abnormalities in critically ill patients
title_short Coagulation abnormalities in critically ill patients
title_sort coagulation abnormalities in critically ill patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750988/
https://www.ncbi.nlm.nih.gov/pubmed/16879728
http://dx.doi.org/10.1186/cc4975
work_keys_str_mv AT levimarcel coagulationabnormalitiesincriticallyillpatients
AT opalstevenm coagulationabnormalitiesincriticallyillpatients